Aquestive Therapeutics Inc
AQST3.925USD
+0.105+2.75%
시장 운영 시간 （ET）시세는 15분 지연됩니다
389.82M시가총액
손실P/E TTM
자세한 내용은 Aquestive Therapeutics Inc 회사
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on treating diseases of the central nervous system (CNS). Its PharmFilm technology is comprised of proprietary polymer compositions that serve as film formers to hold active pharmaceutical ingredients (APIs), and excipients in place. Its product portfolio and pipeline include Anaphylm, AQST-108, and Adrenaverse. Its CNS product candidate include Libervant. The Company’s Licensed commercial products and product candidates and other product includes Suboxone, Exservan, KYNMOBI, Zuplenz, Azstarys, Libervant, and Sympazan. Anaphylm is a non-device based, orally delivered epinephrine product candidate.
회사 정보
종목 코드 AQST
회사 이름Aquestive Therapeutics Inc
상장일Jul 25, 2018
CEOMr. Daniel Barber
직원 수142
유형Ordinary Share
회계 연도 종료Jul 25
주소30 Technology Dr
도시WARREN
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호07059-5166
전화19089411900
웹사이트https://aquestive.com/
종목 코드 AQST
상장일Jul 25, 2018
CEOMr. Daniel Barber
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
313.57K
+24.59%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
303.11K
+27.67%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
293.84K
+26.99%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
156.86K
-1.70%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Dr. Marco Taglietti, M.D.
Dr. Marco Taglietti, M.D.
Independent Director
Independent Director
--
--
Mr. Timothy E. Morris, CPA
Mr. Timothy E. Morris, CPA
Independent Director
Independent Director
--
--
Ms. Stephanie Carrington
Ms. Stephanie Carrington
Investor Relations
Investor Relations
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
313.57K
+24.59%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
303.11K
+27.67%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
293.84K
+26.99%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
156.86K
-1.70%
수익 분석
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
데이터 없음
지역별USD
이름
수익
비율
United States
5.20M
0.00%
Ex-United States
3.52M
0.00%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Fri, May 23
마지막 업데이트: Fri, May 23
주주
주주 유형
주주
주주
비율
Crestline Investors, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.48%
The Vanguard Group, Inc.
4.10%
Perceptive Advisors LLC
3.75%
Armistice Capital LLC
2.77%
Other
74.02%
주주
주주
비율
Crestline Investors, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.48%
The Vanguard Group, Inc.
4.10%
Perceptive Advisors LLC
3.75%
Armistice Capital LLC
2.77%
Other
74.02%
주주 유형
주주
비율
Investment Advisor
16.61%
Hedge Fund
16.46%
Individual Investor
6.00%
Investment Advisor/Hedge Fund
5.80%
Private Equity
5.10%
Research Firm
4.75%
Bank and Trust
0.10%
Venture Capital
0.08%
Pension Fund
0.02%
Other
45.09%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
267
54.56M
54.93%
-2.83M
2025Q1
270
54.42M
54.80%
-3.81M
2024Q4
246
52.68M
57.78%
-5.60M
2024Q3
235
56.04M
61.46%
+1.93M
2024Q2
197
48.34M
53.08%
-1.69M
2024Q1
166
46.95M
51.85%
+18.59M
2023Q4
129
27.01M
40.12%
+751.99K
2023Q3
131
26.75M
41.08%
+3.52M
2023Q2
143
22.79M
40.65%
+3.05M
2023Q1
161
18.71M
33.39%
-2.52M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Crestline Investors, Inc.
9.81M
9.88%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
5.48%
-78.94K
-1.43%
Mar 31, 2025
The Vanguard Group, Inc.
4.07M
4.1%
-273.20K
-6.29%
Mar 31, 2025
Perceptive Advisors LLC
3.73M
3.75%
+3.73M
--
Mar 31, 2025
Armistice Capital LLC
2.75M
2.77%
+2.75M
--
Sep 30, 2024
Barber (Daniel)
1.85M
1.86%
+462.91K
+33.44%
Mar 21, 2025
Geode Capital Management, L.L.C.
1.70M
1.71%
+46.11K
+2.79%
Mar 31, 2025
State Street Global Advisors (US)
1.52M
1.53%
+18.76K
+1.25%
Mar 31, 2025
Pale Fire Capital SE
1.34M
1.34%
+809.93K
+154.05%
Mar 31, 2025
BofA Global Research (US)
1.33M
1.34%
+640.24K
+92.75%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
Invesco NASDAQ Future Gen 200 ETF
0.55%
iShares Micro-Cap ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
더 보기
Invesco NASDAQ Future Gen 200 ETF
비율0.55%
iShares Micro-Cap ETF
비율0.06%
Invesco Nasdaq Biotechnology ETF
비율0.04%
ProShares Ultra Nasdaq Biotechnology
비율0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.03%
ProShares Hedge Replication ETF
비율0.01%
iShares Russell 2000 Value ETF
비율0.01%
ProShares UltraPro Russell2000
비율0.01%
Proshares Ultra Russell 2000
비율0.01%
Global X Russell 2000 ETF
비율0.01%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
